IL1B and amyloidosis: Sustained transgenic IL-1 over-expression, as well as in vitro exposure to IL-1, contributes to a reduction in amyloid pathology, mediated by enhancement of microglia-dependent plaque degradation, with no evidence for IL-1-associated apoptosis of neurons [31].